Channel:  Aligning Science Across Parkinson's (ASAP)

534 Articles

GPNMB and glycosphingolipid measurements in cerebrospinal fluid and plasma from Parkinson's disease patients
Fernandez-Suarez, M. E., Bush, R. J., Di Biase, E., Te Vruchte, D., Priestman, D., Cortina-Borja, M., Cooper, O., Hardy, J., Hallett, P., Isacson, O., Platt, F. M.
10.64898/2026.04.09.712000 — Posted: 2026-05-18
Elucidating the dysbiotic features of gut microbiome, interaction with the human genome, and utility as a biomarker for treatment of Parkinson disease.
Payami, H., Murchison, C. F., Antonello, G., Wallen, Z. D., Dean, M. N., Verster, A., Long, K. R., Waldron, L. D., Sampson, T. R., Standaert, D. G.
10.64898/2026.05.12.724602 — Posted: 2026-05-15
PINK1/Parkin-dependent mitophagy mediates astrocytic inflammatory responses to mitochondrial damage
Riley, J. F., Robbins, C. V., Holzbaur, E. L. F.
10.64898/2026.05.11.724378 — Posted: 2026-05-13
ATP13A4 gates extracellular polyamine levels to control excitatory synaptogenesis
van Veen, S., Meeus, E., Irala, D., Sakers, K., Liu, Z., Savage, J., Sejourne, G., Bindu, D. S., Ausloos, E., Grzesik, H. E., Dhondt, H., Schoonvliet, N., Van den Haute, C., Van Asselberghs, J., Montpeyo Garcia-Moreno, M., Wierda, K., Baekelandt, V., Platzer, K., Rostasy, K., Yap, K. L., Eggermont, J., Holt, M., Eroglu, C., Vangheluwe, P.
10.1101/2025.04.04.25325117 — Posted: 2026-05-12
Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson's disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
Ma, Y., Erb, M. L., Sipple, K. A., Offerman, A. V., Niu, J., Madaj, Z. B., Fu, Z., Lau, K. H., Moore, D. J.
10.64898/2025.12.31.697225 — Posted: 2026-05-12
Para-subthalamic nucleus adjoins subthalamic nucleus and medial forebrain bundle, major DBS-targets in Parkinsons disease, OCD, and depression
Dumas, S., Francois, C., Biviano Rosenkilde, M., Roostalu, U., Karachi, C., Wallen-Mackenzie, A.
10.1101/2025.05.21.655268 — Posted: 2026-05-11
An isogenic single-cell atlas of familial Parkinson's disease mutations reveals convergent changes in dopamine neurons
Syed, K. M., Dunnack, J., Paatz, S., Ajjarapu, K., Sahagun, A., Rio, D., Soldner, F., Bateup, H., Hockemeyer, D.
10.64898/2026.05.04.722458 — Posted: 2026-05-10
A human lysosomal storage disorder toolkit for decoding proteome landscapes in cortical and dopaminergic-like induced neurons
Kraus, F., He, Y., Jiang, Y., Li, D., Ambaw, Y. A., Gasparoli, F. M., Paulo, J. A., Walther, T. C., Farese, R., Gygi, S. P., Wilfling, F., Harper, J. W.
10.1101/2025.10.08.681047 — Posted: 2026-05-10
Cortical synaptic vulnerabilities revealed in a α-synuclein aggregation model of Parkinson's disease
Sah, S., Sauerbeck, A. D., Gupta, J., Perez-Acuna, D., Reiber, J. E., Russell, D., Goralski, T., Henderson, M., Volpicelli-Daley, L. A., Higley, M. J., Kummer, T. T., Biederer, T.
10.1101/2024.06.20.599774 — Posted: 2026-05-08
Utilizing Intraindividual Cognitive Variability to Predict Stage 2 Neuronal Synuclein Disease Progression
Combs, H. L., Kurth, R., Nair, A., York, M. K., Weintraub, D., Lafontant, D.-E., Caspell-Garcia, C., and the Parkinson's Progression Markers Initiative
10.1101/2025.10.21.25338482 — Posted: 2026-05-01

RSS  Channel RSS